If you need more lookups,
subscriptions start at $34 USD/month.
Matthew Miner Location
New York, NY, US
Matthew Miner Work
2024 -now Sr Director, QC Bioanalytics @
2022 -2024 Vice President, Global Quality Control @
2018 -2022 Head, Quality Control @
2010 -2018 Director, QC Microbiology @ Eli Lilly and Company
2004 -2010 Assoc. Dir, QC Microbiology @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
2001 -2004 Manager, QC Microbiology @
2001 -2001 Supervisor, Manufacturing @
1998 -2001 Lab Analyst II @
1996 -1998 Lab Analyst I @
1995 -1995 Lab Analyst I @ Burroughs Wellcome
Matthew Miner Education
East Carolina University
BS (Biology)
1989-1994
Matthew Miner Skills
Technology Implementation
Complaint Management
Product Testing
Environmental Monitoring
Critical Thinking
Gene Therapy
Cell Therapy
Cross-functional Team Leadership
Problem Solving
Leadership
Communication
Business Planning
Resource Planning
Preventive Actions
OOS
Contamination Control
Contamination
Continuous Improvement
Good Laboratory Practice (GLP)
Manufacturing Operations Management
Manufacturing Operations
Quality Management
Aseptic Technique
Strategic Thinking
Quality Investigations
GMP
Sop
Validation
CAPA
Change Control
FDA
21 CFR Part 11
Biotechnology
Pharmaceutical Industry
Aseptic Processing
LIMS
Laboratory
Microbiology
Quality Control
Biopharmaceuticals
Matthew Miner Summary
Matthew Miner, based in New York, NY, US, is currently a Sr Director, QC Bioanalytics at Cellares. Matthew Miner brings experience from previous roles at NOVAVAX INC, Novartis, Eli Lilly and Company and ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company. Matthew Miner holds a 1989 - 1994 BS in Biology @ East Carolina University. With a robust skill set that includes Technology Implementation, Complaint Management, Product Testing, Environmental Monitoring, Critical Thinking and more. Matthew Miner has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Matthew Miner?
Find contact details for 700 million professionals.